BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 27862098)

  • 1. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
    Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
    Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with novel androgen receptor antagonists and statin for castration-resistant prostate cancer.
    Nakayama H; Sekine Y; Oka D; Miyazawa Y; Arai S; Koike H; Matsui H; Shibata Y; Suzuki K
    Prostate; 2022 Feb; 82(3):314-322. PubMed ID: 34843630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin derivatives as therapeutic agents for castration-resistant prostate cancer.
    Ingersoll MA; Miller DR; Martinez O; Wakefield CB; Hsieh KC; Simha MV; Kao CL; Chen HT; Batra SK; Lin MF
    Cancer Lett; 2016 Dec; 383(1):94-105. PubMed ID: 27687622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin Enhances the Radiosensitivity of Androgen-independent Prostate Cancer Cells
    Oka D; Sekine Y; Tsuji Y; Nakayama H; Miyazawa Y; Arai S; Koike H; Suzuki K
    Anticancer Res; 2024 Jan; 44(1):93-98. PubMed ID: 38159995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
    Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
    J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-density lipoprotein induces proliferation and migration of human prostate androgen-independent cancer cells by an ABCA1-dependent mechanism.
    Sekine Y; Demosky SJ; Stonik JA; Furuya Y; Koike H; Suzuki K; Remaley AT
    Mol Cancer Res; 2010 Sep; 8(9):1284-94. PubMed ID: 20671065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor.
    Sekine Y; Furuya Y; Nishii M; Koike H; Matsui H; Suzuki K
    Biochem Biophys Res Commun; 2008 Jul; 372(2):356-61. PubMed ID: 18489904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk Between Androgen-sensitive and Androgen-insensitive Prostate Cancer Cells.
    Takezawa Y; Izumi K; Machioka K; Iwamoto H; Naito R; Makino T; Kadomoto S; Natsagdorj A; Kadono Y; Keller ET; Zhang J; Mizokami A
    Anticancer Res; 2018 Apr; 38(4):2045-2055. PubMed ID: 29599322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
    Barrett CS; Millena AC; Khan SA
    Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
    Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
    Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin Induces Autophagy and Inhibits Proliferation in Prostate Cancer Cells.
    Miyazawa Y; Sekine Y; Oka D; Nakazawa S; Tsuji Y; Nakayama H; Suzuki K
    Anticancer Res; 2023 Dec; 43(12):5377-5386. PubMed ID: 38030198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.
    Ren S; Liu Y; Xu W; Sun Y; Lu J; Wang F; Wei M; Shen J; Hou J; Gao X; Xu C; Huang J; Zhao Y; Sun Y
    J Urol; 2013 Dec; 190(6):2278-87. PubMed ID: 23845456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
    Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
    Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription.
    Liu C; Wang C; Wang K; Liu L; Shen Q; Yan K; Sun X; Chen J; Liu J; Ren H; Liu H; Xu Z; Hu S; Xu D; Fan Y
    J Natl Cancer Inst; 2013 Nov; 105(22):1719-28. PubMed ID: 24174655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression.
    Kim JK; Kim PJ; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Shan JM; Ping WY; Park WS; Lee JY; Nam SW
    Oncol Rep; 2010 Sep; 24(3):607-12. PubMed ID: 20664964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins.
    Furuya Y; Sekine Y; Kato H; Miyazawa Y; Koike H; Suzuki K
    Prostate Int; 2016 Jun; 4(2):56-60. PubMed ID: 27358845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total glucosides of paeony inhibits lipopolysaccharide-induced proliferation, migration and invasion in androgen insensitive prostate cancer cells.
    Zhang ZH; Xie DD; Xu S; Xia MZ; Zhang ZQ; Geng H; Chen L; Wang DM; Wei W; Yu DX; Xu DX
    PLoS One; 2017; 12(8):e0182584. PubMed ID: 28783760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells.
    Glynn SA; O'Sullivan D; Eustace AJ; Clynes M; O'Donovan N
    BMC Cancer; 2008 Jan; 8():9. PubMed ID: 18199328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts.
    Gordon JA; Midha A; Szeitz A; Ghaffari M; Adomat HH; Guo Y; Klassen TL; Guns ES; Wasan KM; Cox ME
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):21-7. PubMed ID: 26238234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.